Samsung BioLogics Co Ltd (XKRX:207940)
â‚© 953000 24000 (2.58%) Market Cap: 67.83 Til Enterprise Value: 67.81 Til PE Ratio: 66.45 PB Ratio: 6.61 GF Score: 88/100

Samsung Biologics Co Ltd at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 13, 2021 / 02:10PM GMT
Release Date Price: â‚©821282.09 (+1.47%)
Tae Jin Park
JPMorgan Chase & Co. - Senior Country Officer & Location Head of Korea

Hi, I'm TJ Park, senior country officer for JPMorgan Korea. Today, I'm very pleased and honored to introduce John Rim as a presenter for Samsung Biologics. John took the helm of Samsung Biologics in December 2020 to lead the exco's phase as the new CEO and President of the company. Since he joined Samsung Biologics in 2018, he contributed to the expansion of the global business portfolio and operational excellence as Executive Vice President. John has served in a variety of senior leadership roles throughout his 35 years of experience in the biopharmaceutical industry.

Today, he will share his vision and Samsung Biologics' strategic direction in this challenging environment. Without further ado, let me hand it over to John Rim.

John Chongbo Rim
Samsung Biologics Co.,Ltd. - CEO, President & Director

Thank you, TJ, for the kind introduction. Good morning, good evening, everybody. It's great to be here with you today. I'm John Rim, CEO of Samsung Biologics.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot